1. Home
  2. FTAIN vs WGSWW Comparison

FTAIN vs WGSWW Comparison

Compare FTAIN & WGSWW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

FTAIN

FTAI Aviation Ltd. 8.25% Fixed - Rate Reset Series C Cumulative Perpetual Redeemable Preferred Shares

N/A

Current Price

$25.18

Market Cap

0.0

Sector

Industrials

ML Signal

N/A

Logo GeneDx Holdings Corp.

WGSWW

GeneDx Holdings Corp.

HOLD

Current Price

$0.00

Market Cap

0.0

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
FTAIN
WGSWW
Founded
N/A
2017
Country
United States
United States
Employees
580
1300
Industry
Misc Corporate Leasing Services
Retail: Computer Software & Peripheral Equipment
Sector
Industrials
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
N/A
N/A
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
FTAIN
WGSWW
Price
$25.18
$0.00
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
3.2K
102.9K
Earning Date
N/A
02-18-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$305,450,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
50.79
52 Week Low
$24.34
$0.00
52 Week High
$25.89
$0.25

Technical Indicators

Market Signals
Indicator
FTAIN
WGSWW
Relative Strength Index (RSI) 34.57 33.30
Support Level $24.98 $0.01
Resistance Level $25.38 $0.02
Average True Range (ATR) 0.11 0.00
MACD -0.05 0.00
Stochastic Oscillator 33.79 18.24

Price Performance

Historical Comparison
FTAIN
WGSWW

About FTAIN FTAI Aviation Ltd. 8.25% Fixed - Rate Reset Series C Cumulative Perpetual Redeemable Preferred Shares

FTAI Aviation Ltd is an aerospace company. It owns and maintains commercial jet engines with a focus on CFM56 engines. FTAI owns and leases jet aircraft, which often facilitates the acquisition of engines at attractive prices. It invests in aviation assets and aerospace products that generate stable cash flows with the potential for earnings growth and asset appreciation.

About WGSWW GeneDx Holdings Corp.

GeneDx Holdings Corp focuses on genomics, creating the foundation for providing genomic information at scale and pioneering exome and genome sequencing for rare and ultra-rare genetic pediatric disorders. The company believes exome and genome testing will become the standard for diagnosing genetic disease, with the potential to transform healthcare from reactive to proactive. It aims to advance precision medicine by offering genetic diagnoses at the earliest moments, driving improved outcomes, and fueling discovery with genomic intelligence. Its operating segment mainly provides pediatric and rare disease diagnostics, focusing on whole exome and genome sequencing and, to a lesser extent, data and information services.

Share on Social Networks: